HOME >> BIOLOGY >> NEWS
Experimental hantavirus vaccine elicits strong antibody response in primates

For the first time, scientists have demonstrated that an experimental vaccine to hantavirus pulmonary syndrome (HPS), a highly lethal disease, elicits a strong neutralizing antibody response in laboratory animals--a response that is key to preventing the virus from causing infection.

In addition, the antibodies, produced in nonhuman primates that received the vaccine, protected hamsters from disease even when administered 5 days after exposure.

These findings provide proof of concept in nonhuman primates for a vaccine against HPS, as well as for post exposure prophylactic treatment of HPS and a related disease known as hemorrhagic fever with renal syndrome (HFRS).

In an article published in last month's Journal of Virology, investigators at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) describe using a naked DNA approach to develop a hantavirus vaccine. The technique involves vaccination with plasmid DNA that encodes a specific hantavirus gene. When the plasmid DNA is introduced into the cells of a vaccine recipient, using a harmless device called a "gene gun," the cloned gene is expressed and presented to the immune system.

According to senior author Jay W. Hooper, Ph.D., the USAMRIID team constructed an expression plasmid containing the full-length M genome segment of Andes virus, a South American hantavirus. Vaccination with the plasmid elicited a potent neutralizing antibody response in rhesus macaques that were vaccinated a total of four times at three-week intervals.

To look at the duration of that response, the team collected serum samples for about six months. The monkeys who received the Andes vaccine displayed robust antibody levels as long as 25 weeks after the last vaccination.

Hantaviruses are carried by rodents and have caused epidemics in Europe, Asia, and the Americas. Some cause HPS, while others are responsible for the more common HFRS. The viruses are patho
'"/>

Contact: Caree Vander Linden
Caree.Vander-Linden@amedd.army.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases
23-Oct-2003


Page: 1 2 3

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure
7. Experimental Biology 2003 meets in San Diego April 11-15
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental gene switch increases lifespan with no ill effects
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... British Columbia (PRWEB) , ... October 09, 2019 ... ... Sigma Anti-Bonding Calcium Symposium (ISACS) 2019 at Executive Plaza Hotel in Vancouver, Canada ... and share the knowledge of the various measures to develop healthy bone and ...
(Date:10/8/2019)... ... October 07, 2019 , ... Imaging data sets are generated ... optical projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and X-ray ... inhouse, a lot of research groups struggle with transforming these large and sometimes ...
(Date:10/3/2019)... ... October 01, 2019 , ... The CHEM+POUR Bag ... medias and to be a more environmentally sustainable evolution to plastic or glass ... experience and feedback from the original version we launched in September 2015,” said ...
Breaking Biology News(10 mins):
(Date:9/24/2019)... ... September 24, 2019 , ... Personalized ... training and site qualification for clinical trial sites and physician investigators. The ... potential clinical trial participants. , Clinical trial sites are currently located in San ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... In the ... for research led by faculty at South Dakota School of Mines & Technology ... tiny microbes that attach to surfaces to form a slimy and yet strong layer ...
(Date:9/17/2019)... ... September 17, 2019 , ... Catalent, ... Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming ... on Sept. 25-26, 2019. , On Thursday, Sept. 26, at 10:10 a.m., Ms. ...
(Date:9/17/2019)... ... September 17, 2019 , ... Geneticure, Inc., a Rochester ... today that the U.S. Patent and Trademark Office (USPTO) and European Patent Office ... class recommendations for hypertension treatment. , The patent applies to Geneticure’s first ...
Breaking Biology Technology:
Cached News: